JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

A dengue transmission model in Thailand considering sequential infections with all four serotypes.

BACKGROUND: Dengue fever/dengue haemorrhagic fever is prevalent in Thailand, where all serotypes are found and the dominant serotype has changed irregularly. Although almost all primary infections present with slight symptoms or are asymptomatic, little is known about the infectiousness of dengue fever.

METHODOLOGY: A mathematical model of the transmission for dengue virus was constructed covering the possibility of sequential infections with all four different serotypes. The model was combined with the seasonal population dynamics of Aedes aegypti, the principal vectors of dengue virus in Thailand. The contributions of inapparent cases in the transmission to mosquito vectors and antibody-dependent enhancement were incorporated into the model. Moreover, the hypothesis of an "unnatural" infection route was examined, where a person acquires immunity by infection during a cross-immunity period, through model simulations.

RESULTS: A comparative study on the transmission probabilities of inapparent cases to mosquito vectors showed that the prevalence of dengue infection could be immediately stamped out after a severe outbreak if inapparent cases had no infectiousness. The simulation under an "unnatural" infection route assumption resulted of yearly changes in the dominant serotype and sharp, irregular variations in outbreaks.

CONCLUSION: The supposition that inapparent cases had no infectiousness was not in accord with the actual situation in Thailand. Furthermore, the simulation result supported the "unnatural" infection route as having an influence on epidemics of dengue.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app